Literature DB >> 507796

Use of covalently closed circular deoxyribonucleic acid for prescreening for antitumor compounds.

S Mong, J E Strong, J A Bush, S T Crooke.   

Abstract

The interactions of PM-2 deoxyribonucleic acid (DNA) with 20 known antineoplastic agents were studied using agarose gel electrophoresis and fluorescence assay systems. Actinomycin D and adriamycin (and all other anthracyclines studied) induced superhelical conformational changes in PM-2 DNA. Bleomycin A2, tallysomycin, neocarzinostatin, macromomycin, and hedamycin degraded PM-2 DNA under various conditions. The potential utility of PM-2 DNA as an antitumor antibiotic prescreening tool was further studied by examining the effects of 200 broths on PM-2 DNA employing both fluorescence and agarose gel electrophorectic assays. The assays were shown to be sensitive and rapid and to provide information not provided by other prescreens with which the PM-2 DNA assays were compared.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507796      PMCID: PMC352867          DOI: 10.1128/AAC.16.3.398

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  SYSTEM FOR DETECTING INDUCERS OF LYSOGENIC ESCHERICHIA COLI W1709 (LAMBDA) AND ITS APPLICABILITY AS A SCREEN FOR ANTINEOPLASTIC ANTIBIOTICS.

Authors:  K E PRICE; R E BUCK; J LEIN
Journal:  Appl Microbiol       Date:  1964-09

2.  Microbiological assays and bioautography of maytansine and its homologues.

Authors:  L J Hanka; M S Barnett
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

3.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.

Authors:  J W Lown; S K Sim; K C Majumdar; R Y Chang
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

4.  Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double- and single-stranded DNAs.

Authors:  P H Johnson; L I Grossman
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

5.  Bristol Laboratories Division, Bristol-Myers Company, Syracuse, N.Y.

Authors:  W T Bradner
Journal:  Antibiot Chemother (1971)       Date:  1978

6.  DNA breakage by tallysomycin.

Authors:  J E Strong; S T Crooke
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

7.  DNA double-strand breaks and alkali-labile bonds produced by bleomycin.

Authors:  L F Povirk; W Wübter; W Köhnlein; F Hutchinson
Journal:  Nucleic Acids Res       Date:  1977-10       Impact factor: 16.971

8.  Two actions of bleomycin on superhelical DNA.

Authors:  S L Ross; R E Moses
Journal:  Biochemistry       Date:  1978-02-21       Impact factor: 3.162

9.  The mechanism of the bleomycin-induced cleavage of DNA.

Authors:  J W Lown; S K Sim
Journal:  Biochem Biophys Res Commun       Date:  1977-08-22       Impact factor: 3.575

10.  Bleomycin-specific fragmentation of double-stranded DNA.

Authors:  R S Lloyd; C W Haidle; D L Robberson
Journal:  Biochemistry       Date:  1978-05-16       Impact factor: 3.162

View more
  2 in total

1.  Mechanism of action of dnacin B1, a new benzoquinoid antibiotic with antitumor properties.

Authors:  S Tanida; T Hasegawa; M Yoneda
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

Review 2.  Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.

Authors:  P C Hydes; M J Russell
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.